JP2022532547A5 - - Google Patents
Info
- Publication number
- JP2022532547A5 JP2022532547A5 JP2021566106A JP2021566106A JP2022532547A5 JP 2022532547 A5 JP2022532547 A5 JP 2022532547A5 JP 2021566106 A JP2021566106 A JP 2021566106A JP 2021566106 A JP2021566106 A JP 2021566106A JP 2022532547 A5 JP2022532547 A5 JP 2022532547A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- composition according
- oral immunotherapy
- quality
- period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962846481P | 2019-05-10 | 2019-05-10 | |
| US62/846,481 | 2019-05-10 | ||
| US201962855384P | 2019-05-31 | 2019-05-31 | |
| US62/855,384 | 2019-05-31 | ||
| US202062967948P | 2020-01-30 | 2020-01-30 | |
| US62/967,948 | 2020-01-30 | ||
| PCT/US2020/032179 WO2020231843A1 (en) | 2019-05-10 | 2020-05-08 | Methods for improving the quality of life of a patient with a peanut allergy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022532547A JP2022532547A (ja) | 2022-07-15 |
| JP2022532547A5 true JP2022532547A5 (https=) | 2023-05-11 |
| JP7574222B2 JP7574222B2 (ja) | 2024-10-28 |
Family
ID=73289227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566106A Active JP7574222B2 (ja) | 2019-05-10 | 2020-05-08 | ピーナツアレルギー患者の生活の質を改善するための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11229673B2 (https=) |
| EP (1) | EP3965815A4 (https=) |
| JP (1) | JP7574222B2 (https=) |
| CN (1) | CN113966229A (https=) |
| AU (1) | AU2020276213A1 (https=) |
| CA (1) | CA3137295A1 (https=) |
| WO (1) | WO2020231843A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014159609A1 (en) | 2013-03-14 | 2014-10-02 | Allergen Research Corporation | Peanut formulations and uses thereof |
| US12433945B2 (en) | 2018-08-16 | 2025-10-07 | Société des Produits Nestlé S.A. | Peanut oral immunotherapy with maintenance dose |
| US12226448B2 (en) | 2018-12-20 | 2025-02-18 | Société des Produits Nestlé S.A. | Peanut oral immunotherapy dosing schedule for missed doses |
| WO2022003604A1 (en) | 2020-07-01 | 2022-01-06 | Société des Produits Nestlé S. A. | Determining medical staffing for oral immunotherapy |
| KR20230148769A (ko) | 2022-04-15 | 2023-10-25 | 사회복지법인 삼성생명공익재단 | 경구면역요법을 이용한 식품알레르기 치료서비스 제공방법, 이를 구현하기 위한 기록매체에 저장된 컴퓨터 프로그램 및 시스템 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3809767A (en) | 1969-05-12 | 1974-05-07 | Griffith Laboratories | Methods of making vegetable protein concentrates |
| AU1589492A (en) | 1991-03-01 | 1992-10-06 | Warner-Lambert Company | Starch-based controlled release compositions |
| US20120164306A1 (en) | 1993-08-03 | 2012-06-28 | Girsh Leonard S | Process for preparing hypoallergenic and reduced fat foods |
| JP3445593B2 (ja) | 1994-09-10 | 2003-09-08 | 株式会社林原生物化学研究所 | ペプチドとその用途 |
| AU2065801A (en) | 1999-12-06 | 2001-06-12 | Panacea Pharmaceuticals, Llc | Passive desensitization |
| AU1951001A (en) | 2000-04-06 | 2001-09-17 | Panacea Pharm Llc | Microbial delivery system |
| WO2004047793A1 (en) | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
| EP1599185A1 (en) | 2003-02-28 | 2005-11-30 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| EP1734975B1 (en) | 2004-03-19 | 2015-06-10 | Herbs Spring, LLC | Herbal therapy for the treatment of food allergy |
| WO2005100995A2 (en) | 2004-04-06 | 2005-10-27 | Mount Sinai School Of Medicine | Methods of determining allergen response using microarray imminoassay techinques |
| BRPI0520821A2 (pt) | 2005-12-28 | 2009-06-30 | Teva Pharma | formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada |
| US8309088B2 (en) | 2007-08-10 | 2012-11-13 | Regeneron Pharmaceuticals, Inc. | Method of treating osteoarthritis with an antibody to NGF |
| HRP20200284T1 (hr) | 2008-10-02 | 2020-07-10 | Salix Pharmaceuticals, Ltd. | Postupci liječenja hepatičke encefalopatije |
| BRPI0921507A2 (pt) | 2008-11-19 | 2016-01-19 | Avantor Performance Mat Inc | composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo |
| US8399519B2 (en) | 2008-12-19 | 2013-03-19 | Merz Pharma Gmbh & Co. Kgaa | 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| US8329208B2 (en) | 2009-07-28 | 2012-12-11 | Methylation Sciences International Srl | Pharmacokinetics of S-adenosylmethionine formulations |
| EP2364690A1 (en) | 2010-02-12 | 2011-09-14 | Centro De Ingenieria Genetica Y Biotecnologia | Orally administrable pharmaceutical pellet of epidermal growth factor |
| JP5800527B2 (ja) | 2010-03-30 | 2015-10-28 | 日東電工株式会社 | 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法 |
| AR081776A1 (es) | 2010-06-30 | 2012-10-17 | Novartis Ag | Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion |
| GB201104537D0 (en) * | 2011-03-17 | 2011-05-04 | Cambridge Entpr Ltd | Treatment for peanut allergy |
| US20140207105A1 (en) | 2011-08-31 | 2014-07-24 | Perosphere, Inc. | Methods for Effectively and Rapidly Desensitizing Allergic Patients |
| WO2013087119A1 (en) | 2011-12-16 | 2013-06-20 | Hal Allergy Holding B.V. | Pharmaceutical formulations and the use thereof for the treatment of peanut allergy |
| CN104080465A (zh) | 2012-01-13 | 2014-10-01 | 科.汉森有限公司 | 用于预防或治疗上呼吸道感染的鼠李糖乳杆菌和动物双歧杆菌乳亚种 |
| CN109125283A (zh) | 2013-03-14 | 2019-01-04 | 艾慕恩治疗公司 | 用于口服脱敏的花生制剂的制备 |
| WO2014159609A1 (en) | 2013-03-14 | 2014-10-02 | Allergen Research Corporation | Peanut formulations and uses thereof |
| KR102233251B1 (ko) | 2013-04-03 | 2021-03-26 | 엔-폴드 엘엘씨 | 신규 나노입자 조성물 |
| US9456628B2 (en) | 2013-06-13 | 2016-10-04 | D&E Gillespie Enterpries LLC | Methods and products to provide oral nutritional care to subjects with dementia |
| US20150343075A1 (en) | 2014-06-02 | 2015-12-03 | Aimmune Therapeutics | Placebo formulations and uses thereof |
| EP3185900A4 (en) | 2014-08-25 | 2018-05-02 | Aimmune Therapeutics, Inc. | Egg protein formulations and methods of manufacture thereof |
| GEAP201814459A (en) | 2014-09-04 | 2018-09-10 | Helsinn Healthcare Sa | Medical treatments based on anamorelin |
| UA122670C2 (uk) | 2014-09-08 | 2020-12-28 | Сефалон, Інк. | Спосіб лікування еозинофільної астми у пацієнта |
| JP2020514306A (ja) | 2017-01-13 | 2020-05-21 | アイミューン セラピューティクス，インコーポレイテッド | 経口免疫療法用のナッツ粉および製剤の製造方法 |
| FR3062797B1 (fr) * | 2017-02-10 | 2025-03-07 | Centre Hospitalier Et Univ De Clermont Ferrand | Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide |
| US11369676B2 (en) * | 2017-11-02 | 2022-06-28 | Société des Produits Nestlé S.A. | Methods of oral immunotherapy |
| USD866321S1 (en) | 2018-07-27 | 2019-11-12 | Aimmune Therapeutics, Inc. | Box of boxes for dispensing medicine |
| EP3829632A4 (en) | 2018-07-27 | 2022-05-04 | Société des Produits Nestlé S.A. | SYSTEMS AND METHODS FOR DELIVERING UNIT DOSES OF ORAL IMMUNOTHERAPY |
| USD866322S1 (en) | 2018-07-27 | 2019-11-12 | Aimmune Therapeutics, Inc. | Medicine folio |
| USD866320S1 (en) | 2018-07-27 | 2019-11-12 | Aimmune Therapeutics, Inc. | Box of boxes for dispensing medicine |
| US12433945B2 (en) * | 2018-08-16 | 2025-10-07 | Société des Produits Nestlé S.A. | Peanut oral immunotherapy with maintenance dose |
| AU2019401576A1 (en) | 2018-12-17 | 2021-06-24 | Société des Produits Nestlé S.A. | Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy |
| US12226448B2 (en) | 2018-12-20 | 2025-02-18 | Société des Produits Nestlé S.A. | Peanut oral immunotherapy dosing schedule for missed doses |
| EP3942299A4 (en) | 2019-03-22 | 2023-06-28 | Société des Produits Nestlé S.A. | Systemic allergic response risk assessment in peanut oral immunotherapy |
| WO2020237181A1 (en) | 2019-05-23 | 2020-11-26 | Aimmune Therapeutics, Inc. | Methods of treating peanut allergy by oral immunotherapy with low-dose maintenance |
-
2020
- 2020-05-08 CA CA3137295A patent/CA3137295A1/en active Pending
- 2020-05-08 EP EP20806108.5A patent/EP3965815A4/en active Pending
- 2020-05-08 WO PCT/US2020/032179 patent/WO2020231843A1/en not_active Ceased
- 2020-05-08 US US16/870,696 patent/US11229673B2/en active Active
- 2020-05-08 CN CN202080033786.0A patent/CN113966229A/zh active Pending
- 2020-05-08 JP JP2021566106A patent/JP7574222B2/ja active Active
- 2020-05-08 AU AU2020276213A patent/AU2020276213A1/en active Pending
-
2022
- 2022-09-27 US US17/953,619 patent/US20230090380A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022532547A5 (https=) | ||
| Donovan et al. | Contemporary diagnosis and management of dental erosion | |
| Amato et al. | Assessment of sleep bruxism, orthodontic treatment need, orofacial dysfunctions and salivary biomarkers in asthmatic children | |
| Attin et al. | Composite vertical bite reconstructions in eroded dentitions after 5· 5 years: a case series | |
| US11033543B2 (en) | Methods of providing weight loss therapy in patients with major depression | |
| CN1293573A (zh) | 迟发性运动障碍和其它运动疾病的治疗方法 | |
| Almansob et al. | Comprehensive evaluation of factors that induce gingival enlargement during orthodontic treatment: A cross-sectional comparative study | |
| AlShahrani et al. | Restorative rehabilitation of a patient with dental erosion | |
| Oh et al. | Open Proximal Contact with Implant-Supported Fixed Prostheses Compared with Tooth-Supported Fixed Prostheses: A Systematic Review and Meta-analysis. | |
| Odell | Clinical Problem Solving in Dentistry E-Book: Clinical Problem Solving in Dentistry E-Book | |
| JPS6345218A (ja) | Ｄ―フェンフルラミン含有うつ病用医薬組成物 | |
| Terézhalmy et al. | Physical evaluation in dental practice | |
| Assaf et al. | Four-year follow-up of increased vertical dimension of occlusion using resin composites | |
| Pietrzak et al. | Possibilities of orthodontic-orthopaedic treatment in patients with Down syndrome, based on review of literature and on own observations | |
| Rafatjou et al. | A multidisciplinary approach to a seven year-old patient with incontinentia pigmenti: a case report and five-year follow up | |
| Diniz et al. | Dental erosion in pediatric dentistry: What is the clinical relevance | |
| Mattoo et al. | Parental neglect in early childhood emerging to adulthood self-neglect | |
| PK et al. | Association of recurrent aphthous ulcers with stress among students in an Indian dental institution | |
| Alassar et al. | Custom-made versus prefabricated zirconia crowns for primary molars: A 12-month follow-up | |
| Gerasimidou et al. | Changes in Tooth Mobility and Position in an Established Dentition Following Placement of a New Restoration | |
| Meehan | Screening for dental disease amongst elite athletes | |
| Fares et al. | Hypersensitivity after direct composite restorations versus preformed metal crowns with molars affected with molar-incisor hypomineralization among a group of Egyptian children (a randomized controlled trial (Part I)) | |
| Aronson | Sleep Disordered Breathing Risk in Surgical and Early Class II Correction Orthodontic Population | |
| Sameni et al. | Rehabilitation of Worn Dentition Using Adhesive and Implant Dentistry | |
| WO2025137348A1 (en) | Cyclobenzaprine hcl for use in treating fibromyalgia with early onset response and favorable tolerability and side effect profile |